Compound ID | 1907
Class: Beta-lactam (cephalosporin, third generation)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and against many Enterobacteriaceae but vulnerable to extended-spectum beta-lactamases (ESBL) |
Description: | Semisynthetic Cephalosporine, derived from Cephalosporin C. Oral application |
Year first mentioned: | 1984 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | C=CC1=C(C(=O)O)N2C(=O)[C@H]([C@H]2SC1)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N |
Isomeric SMILES: | C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O |
InChI: | InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1 |
InChI Key: | OKBVVJOGVLARMR-QSWIMTSFSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5362065 |
External links: | |
Guide to Pharmacology: | cefixime |
Main Source: | https://pubmed.ncbi.nlm.nih.gov/11330356/ |
Citations: |
|